Cargando…
5-Azacytidine and Resveratrol Enhance Chondrogenic Differentiation of Metabolic Syndrome-Derived Mesenchymal Stem Cells by Modulating Autophagy
Recently, metabolic syndrome (MS) has gained attention in human and animal metabolic medicine. Insulin resistance, inflammation, hyperleptinemia, and hyperinsulinemia are critical to its definition. MS is a complex cluster of metabolic risk factors that together exert a wide range of effects on mult...
Autores principales: | Marycz, K., Houston, J. M. Irwin, Weiss, C., Röcken, M., Kornicka, K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535830/ https://www.ncbi.nlm.nih.gov/pubmed/31214275 http://dx.doi.org/10.1155/2019/1523140 |
Ejemplares similares
-
Combination of resveratrol and 5‐azacytydine improves osteogenesis of metabolic syndrome mesenchymal stem cells
por: Marycz, Krzysztof, et al.
Publicado: (2018) -
Extracellular Microvesicles (MV’s) Isolated from 5-Azacytidine-and-Resveratrol-Treated Cells Improve Viability and Ameliorate Endoplasmic Reticulum Stress in Metabolic Syndrome Derived Mesenchymal Stem Cells
por: Weiss, C, et al.
Publicado: (2020) -
Microvesicles isolated from 5-azacytidine-and-resveratrol-treated mesenchymal stem cells for the treatment of suspensory ligament injury in horse—a case report
por: Kornicka-Garbowska, Katarzyna, et al.
Publicado: (2019) -
5‐Azacytydine and resveratrol reverse senescence and ageing of adipose stem cells via modulation of mitochondrial dynamics and autophagy
por: Kornicka, Katarzyna, et al.
Publicado: (2018) -
Dysfunction of Mesenchymal Stem Cells Isolated from Metabolic Syndrome and Type 2 Diabetic Patients as Result of Oxidative Stress and Autophagy may Limit Their Potential Therapeutic Use
por: Kornicka, Katarzyna, et al.
Publicado: (2018)